Björck S, Ahlmén J, Mellstrand T, Stelin G
Acta Med Scand. 1984;215(4):379-82. doi: 10.1111/j.0954-6820.1984.tb05022.x.
Six patients with end-stage renal disease were given prednisolone, 0.7-1.0 mg/kg/b.wt. parenterally. Prednisolone kinetics were investigated during dialysis, in 3 patients on hemodialysis and in 3 on continuous peritoneal dialysis, and also on days without dialysis. Mean plasma half-life was 250 min in five patients and 690 min in one patient who also suffered from intermittent porphyria. No change was found in prednisolone kinetics when the dialysis-free period was compared to the dialysis periods.
6例终末期肾病患者接受了甲泼尼龙治疗,静脉注射剂量为0.7 - 1.0mg/kg/体重。在透析期间对甲泼尼龙的动力学进行了研究,其中3例患者接受血液透析,3例接受持续腹膜透析,同时也在非透析日进行了研究。5例患者的平均血浆半衰期为250分钟,1例同时患有间歇性卟啉病的患者平均血浆半衰期为690分钟。将非透析期与透析期进行比较时,未发现甲泼尼龙动力学有变化。